These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter 2026 revenue growth of approximately 10% on a reported basis and 9% organically, driven by companion animal diagnostics, water and livestock, poultry…
d dairy businesses. The company raised its full-year revenue and earnings outlook, citing strong recurring diagnostics revenue, product-cost benefits and continued momentum from new product introductions
Chief Financial Officer Andrew Emerson said second-quarter revenue growth was supported by more than 10% organic growth in companion animal group, or CAG, Diagnostics recurring revenue. The company generated earnings per share of $4.27, up 18% as reported and 15% on a comparable basis. Diagnostics Growth Outpaces Clinical Visits – Bullish or Bearish?
Vetting Animal Health Care Stocks CAG Diagnostics recurring revenue rose 10.3% organically in the second quarter, including roughly 4% global net price improvement and a 50-basis-point negative impact from equivalent days. U.S. CAG Diagnostics recurring revenue increased nearly 10%, while international recurring revenue grew nearly 12% organically.